That piece of paper was a lesson I never forgot. It emphasized the difference between those who engage in science for the process of discovery, and those who use science as a loose means to an end.
The New York Times today reports on the case of Dr. Joseph Beiderman, a child psychologist at Harvard. Dr. Beiderman received 1.6 million dollars in consulting fees from pharmaceutical companies between 2000 and 2007. His research relating to the use of anti-psychotic drugs in young children is currently being investigated by both Harvard and the US National Institute of Health. One fact that came up during his deposition reminded me of that piece of paper taped to the wall more than 20 years ago.
It seems that Dr. Biederman had given presentations to drug companies telling them what his results were going to be before he started clinical trials. Apparently this made sense to both the drug companies and Dr. Biederman.
All I can say is that Dr. Biederman is no Dave Schindler.
Hat tip: Page Donaldson
Photo Credit: Me.